摘要
牙体缺失后牙槽骨骨量不足向来是口腔种植中最为棘手的问题之一,而经过长期的探索研究,自体骨移植技术、引导性骨再生技术(GBR)等一系列经典术式应运而生,可以说在一定程度上很好地解决了这一问题。其中GBR技术更是以其成骨可预期性好,长期骨吸收率低,易充填塑形,无第二术区,手术并发症少等优势得到了广大种植医生和患者的青睐。然而,随着科技的进步,血小板浓缩物这一新技术开始崭露头角,并凭借着其独有的优势在口腔种植领域的组织增量中占有一席之地,甚至向经典的GBR技术发起了挑战。本文将重点对血小板浓缩物应用在口腔种植领域,特别是组织增量方面的优势作一简要综述。
The lack of alveolar bone volume after tooth loss has always been one of the most knotty problems in dental implantation.After a long period of exploration and research,a series of classical efficient surgical methods such as autogenous bone grafting and guided bone regeneration(GBR)have emerged,which to some extent well solved this problem.GBR technology has been favored by both dentists and patients for its advantages of good predictability of osteogenesis,low long-term bone resorption rate,easy filling and shaping,no second surgical area and fewer complications.However,with the progress of science and technology,platelet concentrate has come to the fore as a new technology.With a lot of unique advantages,platelet concentrate has proven its value in tissue augmentation in dental implant field,and even challenges the classical GBR technology.This article will focus on reviewing the advantages of platelet concentrate in dental implantation,especially in tissue augmentation.
作者
朱靖恺
刘艳
谢超
段妍
马威
ZHU Jingkai;LIU Yan;XIE Chao;DUAN Yan;MA Wei(State Key Laboratory of Military Stomatology&National Clinical Research Center for Oral Diseases&Shaanxi Engineering Research Center for Dental Materials and Advanced Manufacture,Department of Implantology,School of Stomatology,The Fourth Military Medical University,Xi’an 710032,China)
出处
《口腔医学》
CAS
2019年第7期636-641,共6页
Stomatology
